Home» Medical News

FDA seeks court order against Michigan dairy

Views: 98
Date: 03 Sep 2010
Definition of medical terminology for Food.
Definition of medical terminology for Drug Residues.
The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, has filed a complaint for permanent injunction against Scenic View Dairy of Hamilton, Mich., its president, and three of its managers alleging that they sold dairy cows for human consumption that contained illegal drug residues in edible tissues.

Definition of medical terminology for District Hospital.
Definition of medical terminology for Drugs.
Definition of medical terminology for Prescription.
Food Additives Regulatory Management System (CFSAN)
Food Additives Regulatory Management System (CFSAN)
Food Additives Regulatory Management System (CFSAN)
Department of Agriculture (U.S.)
Definition of medical terminology for Letters.
Definition of medical terminology for Tissue.
Definition of medical terminology for Sulfadimethoxine.
Definition of medical terminology for Drug Residues.
Department of Agriculture (U.S.)
Definition of medical terminology for Tissue.
Definition of medical terminology for Human Activities.
Definition of medical terminology for Sulfadimethoxine.
Definition of medical terminology for Food.
Definition of medical terminology for Illegal Abortion.
Definition of medical terminology for Drugs.
Definition of medical terminology for Lead.
Single-celled microorganisms which can exist either as independent (free-living) organisms or as parasites (dependent upon another organism for life).
Definition of medical terminology for Drug Allergies.
Definition of medical terminology for Allergies.
Definition of medical terminology for Regulations.
Definition of medical terminology for Drugs.
Definition of medical terminology for Tissue.
Definition of medical terminology for Slaughterhouses.

The complaint, filed Aug. 31, 2010, in the U.S. District Court for the Western District of Michigan, also alleges that the defendants, despite numerous warnings, sold for slaughter dairy cows that were treated with drugs contrary to the drugsa€™ FDA-approved labeling and without a valid veterinary prescription authorizing such use.


The complaint alleges that violations occurred from 2002 through 2010 at Scenic View Dairya€™s three farms, located in Fennville, Freeport, and Gowen, Mich. Company president Michael D. Geerlings, Fennville farm manager Mark A. Lucas, Freeport farm manager Michael J. Van Dam, and Gowen farm manager Jeremy A. Portell were all named in the complaint.


Between 2001 and 2010, the FDA notified the defendants of its inspectional findings on at least eight occasions, and USDA sent Scenic View at least 11 letters regarding illegal tissue residues. The complaint alleges that the defendants continue to violate the law despite these warnings.


The complaint is based, in part, upon illegal neomycin, penicillin, and sulfadimethoxine drug residues that the USDA found in the edible tissue of dairy cows that defendants had offered for sale for human consumption.


Neomycin, penicillin, and sulfadimethoxine are antibiotics. The sale of animals for human food that contain illegal levels of drugs can lead to the development of bacteria that resist antibiotics and can cause reactions in people with drug allergies. FDA regulations for animal drugs include a specified time to withdraw an animal from treatment prior to slaughter so that a drug is depleted from edible tissue to levels safe for humans.


Scenic View Dairy buys cows primarily from New Hampshire, Pennsylvania and Vermont and sells to slaughterhouses in other states, including Pennsylvania and Wisconsin.


Source : DrugsFreeList.com
Tags: FDA

Latest Medical News

» U.S. Food And Drug Administration Approves Pfizer’s INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
-Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved INLYTA® (axitinib), a kinase inhibitor, for the treatment of patients with advanced renal cell carcinoma (RCC)


» Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia
Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for standard review of bosutinib as a treatment option for adult patients with previously treated Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML).


» FDA approves Inlyta to treat patients with a type of advanced kidney cancer
The U.S. Food and Drug Administration approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.


» FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
The U.S. Food and Drug Administration (FDA) is informing the public that testing positive for anti-JC virus (JCV) antibodies has been identified as a risk factor for progressive multifocal leukoencephalopathy (PML).


» FDA. New and Generic Drug Approvals - January 27, 2012
New drugs approved. List of drugs approved by FDA to date January 27, 2012


» FDA. New and Generic Drug Approvals - January 26, 2012
New drugs approved. List of drugs approved by FDA to date January 26, 2012


» FDA. New and Generic Drug Approvals - January 25, 2012
New drugs approved.List of drugs approved by FDA to date January 25, 2012


» FDA. New and Generic Drug Approvals - January 24, 2012
New drugs approved. List of drugs approved by FDA to date January 24, 2012


» FDA. New and Generic Drug Approvals - January 23, 2012
New drugs approved.List of drugs approved by FDA to date January 23, 2012


» FDA. New and Generic Drug Approvals - January 20, 2012
New drugs approved. List of drugs approved by FDA to date January 20, 2012


» FDA. New and Generic Drug Approvals - January 19, 2012
New drugs approved. List of drugs approved by FDA to date January 19, 2012


» FDA. New and Generic Drug Approvals - January 18, 2012
New drugs approved. List of drugs approved by FDA to date January 18, 2012


» FDA expands use of endovascular graft to treat aortic tears
The U.S. Food and Drug Administration expanded the approved usage for an endovascular graft manufactured by W.L. Gore and Associates Inc. to include treatment of life-threatening tears or ruptures of the aorta (thoracic aortic transection).


» FDA approves Voraxaze to treat patients with toxic methotrexate levels
The U.S. Food and Drug Administration approved Voraxaze (glucarpidase) to treat patients with toxic levels of methotrexate in their blood due to kidney failure.


» FDA Drug Safety Communication: New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin)
The U.S. Food and Drug Administration (FDA) is notifying the public that two additional cases of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection that can result in death, have been reported with the lymphoma drug Adcetris (brentuximab vedotin).


General Search


Last medical tags:


Torisel, temsirolimus, Inlyta, chronic myeloid leukemia, bosutinib, Inlyta, renal cell carcinoma, kidney cancer, myelin, Tysabri, natalizumab, brain infection, progressive multifocal leukoencephalopathy, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, thoracic aortic transection, endovascular graft, methotrexate, Voraxaze, cancer chemotherapy drug, glucarpidase, Adcetris, bleomycin, multifocal leukoencephalopathy, CardioGen-82, radiation, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, raltegravir, Isentress, antiretroviral medicines, Theravance, Relovair, asthma, fluticasone, bronchitis, neuromuscular disease, SMA, muscle atrophy, Resolor, prokinetic, prucalopride, ADHD, psychiatric behavioural disorder, Venvanse, lisdexamfetamine dimesylate, type 2 diabetes mellitus, Actoplus Met XR, pioglitazone, Mylan, Eprosartan Mesylate Tablets, Teveten, antimicrobials, cephapirin, cephalosporin, teriflunomide, Rebif, alanine aminotransferase levels, flu-like symptoms, multiple sclerosis, electrical pulses, implantable pulse generator, Precision Plus Spinal Cord Stimulator, genetic blood clotting disorder, hemophilia A, Advate, bleeding episodes, heart failure, heart transplantation, Pediatric Medical Device Safety, pulsatile cardiac assist device, selective serotonin reuptake inhibitor, SSRI, pulmonary hypertension,
» All tags  
Sitemap